Content is intended for people aged >18 years only
General
Contact: UK Customer Services (Product related enquiries)
E-mail: ukcustomerservices@allergan.com
Telephone: +44 (0) 808 238 1500
Pharmacovigilance
To report an Adverse Event, please contact the Pharmacovigilance Department:
Prescription only medicines
Email: GBPV@abbvie.com
Aesthetic Treatment - e.g. breast implants, Juvederm, HArmonyCa
Email: productsurveillence_eame@allergan.com
Aesthetics - CoolSculpting
Adverse events should be reported. UK reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores.
Irish healthcare professionals (HCPs) are asked to report any suspected adverse reactions via HPRA Pharmacovigilance; website https://www.hpra.ie. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com.
UK-AGNA-230230 Date of Preparation:- June 2024